2 drug(s) with this reaction
1,312 total reports
Drug Exposure During Pregnancy has been reported as an adverse reaction across 2 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,312 adverse event reports mention drug exposure during pregnancy in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with drug exposure during pregnancy, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have drug exposure during pregnancy listed in their FDA adverse event reports, sorted by report count:
In addition to drug exposure during pregnancy, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
2 drug(s) manufactured by Abbvie Inc have drug exposure during pregnancy listed in their FDA adverse event reports: LOPINAVIR AND RITONAVIR, RITONAVIR.
There are a combined 1,312 reports of drug exposure during pregnancy across 2 Abbvie Inc drug(s) in the FDA adverse event database.